A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload

Clinical trial NCT00171821 · COMPLETED

Trial details

NCT number: NCT00171821
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transfusion-dependent Iron Overload

Start date: 2005-04-01
Primary completion: 2009-05-01
Enrollment: 1784

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.